Literature DB >> 7860761

Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study.

J H Hwang1, G Perseghin, D L Rothman, G W Cline, I Magnusson, K F Petersen, G I Shulman.   

Abstract

Hepatic glycogen concentration was measured in six subjects with insulin-dependent diabetes mellitus (IDDM) and nine weight-matched control subjects using 13C nuclear magnetic resonance spectroscopy during a day in which three isocaloric mixed meals were ingested. The relative fluxes of the direct and indirect (3 carbon units-->-->glycogen) pathways of hepatic glycogen synthesis were also assessed using [1-13C]glucose in combination with acetaminophen to noninvasively sample the hepatic UDP-glucose pool. Mean fasting hepatic glycogen content was similar in the two groups. After each meal, hepatic glycogen content increased, peaking 4-5 h after the meal in both groups. By 11:00 p.m. the IDDM subjects had synthesized only 30% of the glycogen that was synthesized by the control group [IDDM subjects, net increment = 44 +/- 20 (mean +/- SE) mM; control subjects, net increment = 144 +/- 14 mM; P < 0.05]. After breakfast the flux through the gluconeogenic pathway relative to the direct pathway of hepatic glycogen synthesis was 1.7-fold greater in the IDDM subjects (59 +/- 4%) than in the control subjects (35 +/- 4%, P < 0.0003). In conclusion, under mixed meal conditions, subjects with poorly controlled IDDM have a major defect in net hepatic glycogen synthesis and augmented hepatic gluconeogenesis. The former abnormality may result in an impaired glycemic response to counterregulatory hormones, whereas both abnormalities may contribute to postprandial hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860761      PMCID: PMC295553          DOI: 10.1172/JCI117727

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Differential effect of hyperglycemia and hyperinsulinemia on pathways of hepatic glycogen repletion.

Authors:  G I Shulman; R A DeFronzo; L Rossetti
Journal:  Am J Physiol       Date:  1991-05

2.  Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

Authors:  D L Rothman; I Magnusson; L D Katz; R G Shulman; G I Shulman
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

3.  Selective population inversion in NMR.

Authors:  M S Silver; R I Joseph; C N Chen; V J Sank; D I Hoult
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

4.  Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans.

Authors:  G I Shulman; G Cline; W C Schumann; V Chandramouli; K Kumaran; B R Landau
Journal:  Am J Physiol       Date:  1990-09

5.  Effect of dietary protein on in vivo insulin action and liver glycogen repletion.

Authors:  L Rossetti; D L Rothman; R A DeFronzo; G I Shulman
Journal:  Am J Physiol       Date:  1989-08

6.  Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans.

Authors:  L Saccà; C Vigorito; M Cicala; G Corso; R S Sherwin
Journal:  Am J Physiol       Date:  1983-09

7.  Pathogenesis of NIDDM. A balanced overview.

Authors:  R A DeFronzo; R C Bonadonna; E Ferrannini
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

8.  Sources of carbon for hepatic glycogen synthesis in the conscious dog.

Authors:  M C Moore; A D Cherrington; G Cline; M J Pagliassotti; E M Jones; D W Neal; C Badet; G I Shulman
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Hypoglycemia in IDDM.

Authors:  P E Cryer; C Binder; G B Bolli; A D Cherrington; E A Gale; J E Gerich; R S Sherwin
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

10.  Suppression of sleep-induced growth hormone secretion by anticholinergic agent abolishes dawn phenomenon.

Authors:  M B Davidson; M D Harris; F H Ziel; C S Rosenberg
Journal:  Diabetes       Date:  1988-02       Impact factor: 9.461

View more
  62 in total

Review 1.  The use of magnetic resonance methods in translational cardiovascular research.

Authors:  Arthur H L From; Kamil Ugurbil
Journal:  J Cardiovasc Transl Res       Date:  2009-01-13       Impact factor: 4.132

2.  Insulin:Carbohydrate Ratio--Part of the Story.

Authors:  Ananda Basu; Rita Basu
Journal:  Diabetes Technol Ther       Date:  2015-12       Impact factor: 6.118

Review 3.  Regulation of hepatic glucose uptake and storage in vivo.

Authors:  Mary Courtney Moore; Katie C Coate; Jason J Winnick; Zhibo An; Alan D Cherrington
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 4.  Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.

Authors:  Pieter C Dagnelie; Susanne Leij-Halfwerk
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

5.  Magnetic Resonance Imaging for Drug Development.

Authors:  Jeong Kon Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Oral Insulin Delivery in a Physiologic Context: Review.

Authors:  Ehud Arbit; Miriam Kidron
Journal:  J Diabetes Sci Technol       Date:  2017-02-02

7.  Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Authors:  Dale S Edgerton; Melanie Scott; Ben Farmer; Phillip E Williams; Peter Madsen; Thomas Kjeldsen; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  JCI Insight       Date:  2019-02-26

8.  Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Authors:  S Kehlenbrink; S Koppaka; M Martin; R Relwani; M-H Cui; J-H Hwang; Y Li; R Basu; M Hawkins; P Kishore
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

9.  Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.

Authors:  Ling Hinshaw; Ashwini Mallad; Chiara Dalla Man; Rita Basu; Claudio Cobelli; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-07       Impact factor: 4.310

10.  Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes.

Authors:  Kitt Falk Petersen; Thomas B Price; Raynald Bergeron
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.